Skip to main content
logo
Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.610
-0.310 (-6.30%)
At close: May 8, 2026, 4:00 PM EDT
4.650
+0.040 (0.87%)
After-hours: May 8, 2026, 5:05 PM EDT

Cytek Biosciences Revenue

Cytek Biosciences had revenue of $44.14M in the quarter ending March 31, 2026, with 6.46% growth. This brings the company's revenue in the last twelve months to $204.17M, up 3.61% year-over-year. In the year 2025, Cytek Biosciences had annual revenue of $201.49M with 0.52% growth.

Revenue (ttm)
$204.17M
Revenue Growth
+3.61%
P/S Ratio
2.92
Revenue / Employee
$301,137
Employees
678
Market Cap
595.35M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025201.49M1.04M0.52%
Dec 31, 2024200.45M7.44M3.85%
Dec 31, 2023193.02M28.98M17.67%
Dec 31, 2022164.04M36.09M28.20%
Dec 31, 2021127.95M35.11M37.82%
Dec 31, 202092.84M34.96M60.39%
Dec 31, 201957.88M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
QuidelOrtho2.66B
Orthofix Medical825.37M
Tactile Systems Technology343.52M
OrthoPediatrics243.30M
Cerus216.56M
SI-BONE200.93M
Pacific Biosciences of California160.03M
NeuroPace99.99M
Revenue Rankings

CTKB News

More News